Fourthly, in human tumors, high expression of SCARB1 is associated with adverse patient outcomes and in experimental models, inhibition of SCARB1 impairs the proliferation, invasion and migration of ccRCC cells44. Here, SCARB1 is linked to nonpapillary renal cell carcinoma.